Related Experiment Video
Updated: Feb 28, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
[Precision Medicine in Obesity Research and Practice]
1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Summary
Obesity is a complex global health issue. Precision medicine advances understanding of its heterogeneity, highlighting the need for better diagnostic and predictive tools.
Area of Science:
- Genomics and biochemistry
- Precision medicine
- Obesity research
Background:
- Obesity is a critical global health problem with significant heterogeneity.
- Advances in genomic and biochemical technologies are driving progress in obesity research.
- Current diagnostic and classification methods face challenges due to obesity's complexity.
Purpose of the Study:
- To highlight the need for predictive models in obesity diagnosis and clinical practice.
- To emphasize the importance of understanding key molecular players in obesity.
- To advocate for further research in precision medicine for obesity treatment.
Main Methods:
- Review of genomic and biochemical advancements in obesity research.
- Analysis of the roles of gastric hormones, feeding/reward system proteins, and gut microbiota.
- Exploration of precision medicine approaches for obesity.
Main Results:
- Obesity is a highly heterogeneous condition.
- Predictive models for obesity are currently lacking.
- Gastric hormones, feeding/reward pathways, and gut microbiota are crucial factors.
Conclusions:
- Further understanding of molecular and genetic factors is essential for obesity management.
- Precision medicine offers a promising avenue for improved obesity diagnosis and treatment.
- Clinical translation of research findings is a key future goal.
More Related Videos
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Drug Dosing: Obese Patients
316
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250

